 |
|
Prognostic Value of Lymph Node Dissection in Malignant Melanoma
Constantine P. Karakousis, MD;
Mohammad K. Seddiq, MD;
Robert Moore, MS
Arch Surg. 1980;115(6):719-722.
Abstract
• Retrospective review of 199 patients with malignant melanoma who had regional node dissection showed that the median survival rates of patients with histologically negative nodes was more than threefold higher than that of patients with histologically positive regional nodes. In the patients with positive nodes, survival was related to the number of nodes involved. Patients with one, two, and three or more positive lymph nodes had a tumor-free five-year survival rate of 41%, 30%, and 18%. Patients who required regional node dissection for positive palpable nodes in one month, one year, or longer than one year from the excision of the primary tumor had a median survival of 21.5, 22, and 44 months.
(Arch Surg 115:719-722, 1980)
Author Affiliations
From the Departments of Surgical Oncology (Drs Karakousis and Seddiq) and Biostatistics (Mr Moore), New York State Department of Health, Roswell Park Memorial Institute, Buffalo.
Footnotes
Accepted for publication Jan 3, 1980.
Reprint requests to Roswell Park Memorial Institute, 666 Elm St, Buffalo, NY 14263 (Dr Karakousis).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Immunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine
Berd et al.
JCO 2004;22:403-415.
ABSTRACT
| FULL TEXT
Theoretical and Empirical Arguments in Relation to Elective Lymph Node Dissection for Melanoma
Piepkorn et al.
Arch Dermatol 1997;133:995-1002.
ABSTRACT
Melanoma Recurrence in a Previously Dissected Lymph Node Basin
Warso and Gupta
Arch Surg 1994;129:252-255.
ABSTRACT
Patterns of Relapse in 1001 Consecutive Patients With Melanoma Nodal Metastases
Calabro et al.
Arch Surg 1989;124:1051-1055.
ABSTRACT
|
